Microbiome alterations are driven by CFTR mutations and are, therefore, inherent to CF (10, 16) but are also likely influenced by CF clinical manifestations, such as pancreatic sufficiency and CFTR genotype (17, -, 19). This evidence concerns the gene CFTR and cystic fibrosis.